Future Opportunities in the Global Zolgensma Drug Market
The Zolgensma Drug Market presents significant future opportunities as gene therapy continues to redefine treatment approaches for rare genetic disorders. Zolgensma’s success has paved the way for broader acceptance of gene-based solutions in modern medicine. With a valuation of USD 1,214 Million in 2023, the market is projected to reach USD 1,539 Million by 2030, expanding at a 5.0% CAGR...
0 Kommentare 0 Geteilt 143 Ansichten 0 Bewertungen
Gesponsert